Extended valganciclovir prophylaxis in D+/R- kidney transplant recipients is associated with long-term reduction in cytomegalovirus disease: two-year results of the IMPACT study.
Humar, Atul
Extended valganciclovir prophylaxis in D+/R- kidney transplant recipients is associated with long-term reduction in cytomegalovirus disease: two-year results of the IMPACT study. [electronic resource] - Transplantation Dec 2010 - 1427-31 p. digital
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1534-6080
10.1097/tp.0b013e3181ff1493 doi
Antiviral Agents--administration & dosage
Cytomegalovirus Infections--epidemiology
Double-Blind Method
Follow-Up Studies
Ganciclovir--administration & dosage
Graft Survival
Humans
Immunoglobulin G--blood
Immunoglobulin M--blood
Kidney Transplantation--adverse effects
Likelihood Functions
Predictive Value of Tests
Prospective Studies
Serologic Tests--statistics & numerical data
Survival Rate
Time Factors
Valganciclovir
Extended valganciclovir prophylaxis in D+/R- kidney transplant recipients is associated with long-term reduction in cytomegalovirus disease: two-year results of the IMPACT study. [electronic resource] - Transplantation Dec 2010 - 1427-31 p. digital
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1534-6080
10.1097/tp.0b013e3181ff1493 doi
Antiviral Agents--administration & dosage
Cytomegalovirus Infections--epidemiology
Double-Blind Method
Follow-Up Studies
Ganciclovir--administration & dosage
Graft Survival
Humans
Immunoglobulin G--blood
Immunoglobulin M--blood
Kidney Transplantation--adverse effects
Likelihood Functions
Predictive Value of Tests
Prospective Studies
Serologic Tests--statistics & numerical data
Survival Rate
Time Factors
Valganciclovir